Loading...
Chemical structure of PLX51107

GC19298

PLX51107

Also known as 4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1S)-1-pyridin-2-ylethyl]pyrrolo[3,2-b]pyridin-3-yl]benzoic acid

PLX51107 is a potent and selective BET inhibitor, with Kds of 1·6, 2·1, 1·7, and 5 nM for BD1 and 5·9, 6·2, 6·1, and 120 nM for BD2 of BRD2, BRD3, BRD4, and BRDT, respectively; PLX51107 also interacts with the bromodomains of CBP and EP300 (Kd, in the 100 nM range)

ChemicalCAS1627929-55-8MW438.48FormulaC26H22N4O3
CAS number
1627929-55-8
Molecular weight
438.48
Formula
C26H22N4O3
Solubility
DMSO : 75 mg/mL (171·05 mM)
InChIKey
AMSUHYUVOVCWTP-INIZCTEOSA-N
Catalogue number
GC19298
Brand
GLPBIO
Computed properties PubChem CID 90448953 · XLogP 4 · TPSA 94 Ų · H-bond donors 1
XLogP
4
TPSA
94 Ų
H-bond donors
1
H-bond acceptors
6
Rotatable bonds
5
Heavy atoms
33

SMILES CC1=C(C(=NO1)C)C2=CC3=C(C(=CN3[C@@H](C)C4=CC=CC=N4)C5=CC=C(C=C5)C(=O)O)N=C2

Computed descriptors from PubChem (CID 90448953), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.